Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor‐resistant reflux oesophagitis
- 29 December 2010
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 33 (5), 601-606
- https://doi.org/10.1111/j.1365-2036.2010.04550.x
Abstract
International audienceBACKGROUND In patients with heartburn persisting despite proton pump inhibitor (PPI) therapy, reflux oesophagitis is rarely found and its pathogenesis has been scarcely studied. AIM To assess reflux parameters by impedance-pH monitoring in PPI-resistant reflux oesophagitis. METHODS Impedance-pH monitoring was performed on PPI therapy in patients with symptomatic reflux oesophagitis detected despite standard or high-dose PPI therapy of at least 8-week duration. RESULTS Twenty patients, ten on once daily and ten on twice daily PPI regimens, were studied. The gastric acid exposure time (percent time pH 30% in 70% of cases but the oesophageal acid exposure time (percent time pH <4) was abnormal in 20% of patients only. The number of acid, weakly acidic and weakly alkaline refluxes was abnormal in 25%, 100% and 15% of patients, respectively. CONCLUSIONS Weakly acidic refluxes were above the normal range in all cases whereas acid reflux parameters and weakly alkaline refluxes were normal in the vast majority of cases. Gastric acid secretion, with consequent intra-gastric pepsins activation, persists despite ongoing PPI therapy and activated pepsins may well be present in weakly acidic refluxes. As activated pepsins maintain their proteolytic activity in a weakly acidic environment, they may be responsible for mucosal damage. We conclude that weakly acidic refluxes have a major role in the pathogenesis of PPI-resistant reflux oesophagitis. Therapeutic interventions in patients with PPI-resistant reflux oesophagitis should be tailored on the basis of impedance pH-monitoring resultsKeywords
This publication has 29 references indexed in Scilit:
- Reflux Parameters as Modified by Laparoscopic Fundoplication in 40 Patients with Heartburn/Regurgitation Persisting Despite PPI Therapy: A Study Using Impedance-pH MonitoringDigestive Diseases and Sciences, 2010
- Management of heartburn not responding to proton pump inhibitorsGut, 2009
- American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux DiseaseGastroenterology, 2008
- Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoringGut, 2006
- Esophageal pH-Impedance Monitoring and Symptom Analysis in GERD: A Study in Patients off and on TherapyThe American Journal of Gastroenterology, 2006
- The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based ConsensusThe American Journal of Gastroenterology, 2006
- A Prospective Study of Gastric Acid Analysis and Esophageal Acid Exposure in Patients with Gastroesophageal Reflux Refractory to Medical TherapyDigestive Diseases and Sciences, 2005
- Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux DiseaseThe American Journal of Gastroenterology, 2005
- Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non‐erosive reflux diseaseAlimentary Pharmacology & Therapeutics, 2003
- Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationGut, 1999